Griffith J F, Fitzwilliam J F, Casagrande S, Butler S R
J Infect Dis. 1975 Nov;132(5):506-10. doi: 10.1093/infdis/132.5.506.
Experimental herpesvirus encephalitis in weanling mice was treated with either cytosine arabinoside or adenine arabinoside to determine the comparative effectiveness of the two compounds on survival and on the concentration of virus in the brain. The uniformly fatal course of the encephalitis was not altered by any dosage of cytosine arabinoside. In contrast, treatment with adenine arabinoside resulted in long-term survival of the majority of the infected animals. The concentration of virus measured in the brains of animals treated with two different dosages of cytosine arabinoside indicated initial suppression of viral replication with a subsequent rise to levels higher than those in the untreated controls. In the brains of adenine arabinoside-treated animals, titers of virus gradually diminished to undetectable levels by the eighth day after institution of therapy.
用阿糖胞苷或阿糖腺苷治疗断奶小鼠的实验性疱疹病毒性脑炎,以确定这两种化合物对小鼠存活及脑中病毒浓度的相对疗效。任何剂量的阿糖胞苷均未改变脑炎的一致致死病程。相比之下,用阿糖腺苷治疗使大多数受感染动物长期存活。用两种不同剂量阿糖胞苷治疗的动物脑内测得的病毒浓度表明,病毒复制起初受到抑制,随后升至高于未治疗对照组的水平。在用阿糖腺苷治疗的动物脑中,病毒滴度在治疗开始后第8天逐渐降至检测不到的水平。